CAS
WST icon

CTC Alternative Strategies’s West Pharmaceutical WST Stock Holding History

CTC Alternative Strategies’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,200
Closed -$395K – 201
2024
Q2 		$395K Buy
+1,200
New +$424K 0.17% 138
2014
Q1 		– Sell
-6,400
Closed -$314K – 219
2013
Q4 		$314K Buy
+6,400
New +$300K 0.24% 66

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CTC Alternative Strategies's WST Position: Q3 2024 in Review

CTC Alternative Strategies sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 1,200 shares — an estimated $395K sold.

CTC Alternative Strategies first reported a position in WST in Q4 2013 and held it in 2 quarters. The position peaked at $395K in Q2 2024. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • CTC Alternative Strategies reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • CTC Alternative Strategies sold 1,200 West Pharmaceutical shares in Q3 2024, an estimated $395K.
  • CTC Alternative Strategies first reported a position in West Pharmaceutical in Q4 2013 and held it in 2 quarters.
  • CTC Alternative Strategies's West Pharmaceutical position peaked at $395K in Q2 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on CTC Alternative Strategies's 13F filing for Q3 2024, filed 15 Nov 2024.